Healthcare -
Biotechnology - NASDAQ - US
$ 6.56
-6.55 %
$ 665 M
Market Cap
-6.85
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Day One Biopharmaceuticals, Inc.
| Revenue | 131 M |
| Cost Of Revenue | 5.28 M |
| Gross Profit | 126 M |
| Operating Expenses | 343 M |
| Operating Income | -217 M |
| Other Expenses | -122 M |
| Net Income | -95.5 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 131.2 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 5.3 | 0.4 | 0.5 | 0.2 | 0.2 | 0 |
| Gross Profit | 125.9 | (0.4) | (0.5) | (0.2) | (0.2) | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 343.2 | 206.1 | 146.9 | 72.7 | 13.8 | 14.9 |
| Selling, General and Administrative Expenses | 115.5 | 75.5 | 61.3 | 29.2 | 4.7 | 1.0 |
| Research and Development Expenses | 227.7 | 130.5 | 85.6 | 43.6 | 9.1 | 13.9 |
| Operating Income | (217.3) | (206.1) | (146.9) | (72.7) | (13.8) | (14.9) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 4.7 | 4 K | 30 K | 2.1 |
| Total Other Income | 128.9 | 17.1 | 4.7 | 11 K | (30.1) | (2.1) |
| Pre-Tax Income | (88.4) | (188.9) | (142.2) | (72.8) | (43.8) | (17.0) |
| NET INCOME | ||||||
| Tax Provision | (7.1) | 0 | (10.0) | (2.3) | (3.3) | (2.3) |
| Net Income | (95.5) | (188.9) | (132.2) | (70.4) | (40.5) | (14.7) |
| EPS | 1.02 | 2.37 | 2.02 | 1.14 | 0.65 | 0.24 |